In more than 10 years since the sequence of the Mycobacterium tuberculosis genome was published, the genetic information of the pathogen and genetic tools have shifted the emphasis of TB drug research. This symposium highlights how they are utilized in the quest for novel TB regimens.
This meeting will be presented by the Emerging Infectious Diseases and Microbiology Discussion Group at the New York Academy of Sciences.
- Helen Boshoff (NIH)
- William R. Jacobs, JR. (Albert Einstein college of Medicine)
- Carl Nathan (Weill Cornell Medical College)
- Christopher Sassetti (University of Massachusetts Medical School)
- Dirk Schnappinger (Weill Cornell Medical College)
The meeting is organized by Takushi Kaneko (TB Alliance) and Jennifer Henry (NYAS).
For more information and to register, please visit www.nyas.org/TB. An online webinar is also available if you are unable to attend in person.